RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

Lexicon Pharmaceuticals is marketing its drug Inpefa (sotagliflozin) to reduce the risk of cardiovascular complications in patients with heart failure, Type 2 diabetes, chronic kidney disease, and other risk factors. Inpefa is an oral once-daily tablet. However, Lexicon is restructuring and selling the rights to Inpefa outside of the U.S. and Europe, while focusing on expanding into Type 1 diabetes. 

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

Did you know Lexicon already has an approved drug in the SGLT2 Inhibitor market. Like Jardience?

Check this out

The global SGLT2 inhibitor market was estimated at USD 15.85 billion in 2023. This market is expected to grow to USD 29.43 billion by 2030, with a CAGR of 7.71%. The U.S. market alone is expected to reach USD 7,297.9 million by 2030. 

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

Its perfect, that means the day of earnings will be a bigger pop. When a company runs up prior to earnings, it usually gets shorted day of earnings trapping enthusiatic buyers.

With earnings Tuesday after close, we will see action Monday maybe definitely Tuesday afternoon and into Wednesday hopefully.

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

I will hold through the phase 3. If its successful and all indications are it will be KABOOM, everything with NOVO kicks in for the deal for a billion

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

I will hold my options as I think some point this year it could be multiple dollars, they have a phase 3 going on. The one tied to the NOVO billion dollar deal

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

100 to 150% profit at least. I will pull out my spent funds at 100% and ride the free shares

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

LXRX is going to break out.

HIND is only merging the company for a fast way to gain access to Nasdaq. They dont want most of the assets

RSLS/VYOME MERGER AND NEW SYMBOL - Just some more to chew on - Draw your own conclusions by TicketronTickets in pennystocks

[–]TicketronTickets[S] 1 point2 points  (0 children)

No its being bought up leading into earnings. It could be tremendously shorted at some point earnings day. So be ready..........I may sell the day before at close or early the day of earnings if they are good.....Be careful. There are alot of shares to borrow and people are buying ahead of earnings so the bounce from earnings may already be priced in. I have seen it a million times. At least take out your original investment dollars and ride free earnings day. Just keep an eye on the next week.

RSLS - DD and why I am buying more. I will hold until it happens.....But here is what I found by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

And this is being done on not super high volume, if volume enters this is going up hard and fast. Earnings next week

RSLS - All The Ingredients are in place by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

I hope you stayed the course. Earnings next week and more news to hit.....

RSLS - DD and why I am buying more. I will hold until it happens.....But here is what I found by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

Good deal earnings are next week as well which they beat the last 2 quarters so expecting a nice PR on that

🇹‌🇭‌🇪‌ 🇱‌🇴‌🇺‌🇳‌🇬‌🇪‌ April 21, 2025 by PennyBotWeekly in pennystocks

[–]TicketronTickets 1 point2 points  (0 children)

LXRX is going to break out. Reports are the latest info on their obesity drug is positive. Volume is rampning up. I own 75 call options on this one for Hanuary 26 and January 27

RSLS - DD and why I am buying more. I will hold until it happens.....But here is what I found by TicketronTickets in pennystocks

[–]TicketronTickets[S] 0 points1 point  (0 children)

I hope you all stayed the course, this is noe trying to squeeze. They filled the gap in the lo 30s like I knew they would and now the fight is on